ANGLE
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10 Nugent Rd, Guildford, Surrey, GU2 7AF...Phone Number
+44 1483343434Website
www.angleplc.comRevenue
<$5 MillionStock Symbol
AGLEIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About ANGLE
ANGLE is a UK-based specialist medtech company commercializing the Parsortix system, a cell separation technology that enables a simple blood test to capture targeted cells for investigation, such as circulating tumor cells (CTCs) for molecular profiling and analysis. Parsortix can help deliver targeted cancer diagnostics that has the potential to inform personalized treatment of cancer. It is also designed to be compatible with existing major medtech analytical platforms and to act as a companion diagnostic for major pharma in helping to identify patients that will benefit from a particular drug and then monitoring the drug's effectiveness. ANGLE has established formal collaborations with world-class cancer centers and is working with these cancer centers to demonstrate key applications for its Parsortix non-invasive cancer diagnostic system as a liquid biopsy. In addition to cancer cells, the Parsortix technology has the potential for deployment for other clinically significant cellRead more
Popular SearchesAngleAngle PLCANGLE North America IncAngle Technology LtdAngle IncSIC Code 38,382NAICS Code 33,334Ticker LON: AGLEShow moreANGLE Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ANGLE your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
ANGLE, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once ANGLE has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if ANGLE had a recent Job posting/layoffs
Earning: See what the market has to say on ANGLE recently announced quarterly report
Product Launch: Get notified when ANGLE launches new products
Check out if ANGLE is spiking on competitors!
Check if ANGLE has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at ANGLE
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to ANGLE
Compare insights from companies similar to ANGLE, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ANGLE is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ANGLE is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ANGLE.
ANGLE Tech Stack
A closer look at the technologies used by ANGLE
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Project
reports that engagement with pharmaceutical companies typically takes about six months before a sale can be made, as the process involves providing specific data from publications to the pharma company.
Sales, Pharmaceuticals
Project
ANGLE is in discussions with the NHS to agree on a suitable clinical study evaluating the benefits of analyzing circulating tumor cells, initially for lung cancer. Adoption by the NHS could drive worldwide interest in ANGLE's technology.
Medical Research, Healthcare Technology
Project
Medical Research, Pharmaceuticals, Healthcare Technology
ANGLE News & Media
Angle PLC Announces Appointment of Non-Executive Director
ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, is delighted to announce that Joseph (Joe) Eid M.D.Angle plc Announces Appointment of Non-Executive Director
ANGLE plc ("the Company") (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, is delighted to announce that Juliet Thompson has been appointed as a Non-Executive Director of the Company, with effect from 5 January 2023.Angle plc Announces Business Update
2022 has been a breakthrough year for ANGLE with the world's first FDA product clearance for a system to harvest cancer cells from patient blood for subsequent analysis following a sustained effort by the Company for over six years including extensive dialogue and formal pre-submissions with FDA, and the submission of over 400 technical reports and documents and processing of over 16,000 samples to demonstrate system performance.Angle PLC Announces Issue of Equity - AccessWire
Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / December 2, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 56,666 new ordinary shares of £0.10 each ("New Ordinary Shares") in the Company. The New Ordinary Shares will rank pari passu with the existing Ordinary Shares in the Company. An
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ANGLE
Sign Up For FreeTo access detailed company insights
ANGLE is a UK-based specialist medtech company commercializing the Parsortix system, a cell separation technology that enables a simple blood test to capture targeted cells for investigation, such as circulating tumor cells (CTCs) for molecular profiling and analysis. Parsortix can help deliver targeted cancer diagnostics that has the potential to... Read More
